2 unknown. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow tecarfarin: new trials by email Literature Review of tecarfarin trials Research Report on tecarfarin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tecarfarin Anti-Coagulation Trial (TACT) Warfarin, tecarfarin - Thromboembolism, Thrombosis | Phase 3 | Unknown | Espero Biopharma | 1000 | 2018-06-01 | 2018-01-25 |
| Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation ATI-5923, Coumadin (warfarin) - Atrial Fibrillation, Atrial Flutter | Phase 2 / Phase 3 | Unknown | ARYx Therapeutics | 600 | 2008-05-01 | 2010-02-02 |
Atrial Fibrillation (1) · Atrial Flutter (1) · Cardiomyopathies (1) · Myocardial Infarction (1) · Renal Insufficiency, Chronic (1) · Thromboembolism (1) · Thrombosis (1)
ARYx Therapeutics (1) · Espero Biopharma (1)
United States (1)